Abstract FR472: Ultra-Processed Food Consumption and Cardiovascular-Kidney-Metabolic Syndrome Among United States Adults: 2011-2023
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.fr472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Yue Zhang und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Ultra-processed foods (UPFs) account for more than half of total energy intake among US adults and are linked to adverse cardiovascular, kidney, and metabolic outcomes. The 2026 AHA/ACC/ADA/ASN clinical practice guideline emphasizes cardiovascular-kidney-metabolic (CKM) syndrome staging as a framework for integrated risk assessment and prevention. However, whether higher UPF intake is associated with more advanced CKM stages remains unclear.
Objective
To examine the cross-sectional association between UPF intake and CKM stages among a nationally representative sample of US adults.
Methods
We included adults aged ≥20 years from the fasting subsample of the National Health and Nutrition Examination Survey 2011-2023. We classified UPF intake using the Nova Food Processing Classification System based on two 24-hour dietary recalls, averaged across days, and expressed as percentage of total energy intake from UPFs. We defined CKM stages per the AHA framework: Stage 0, no risk factors; Stage 1, excess or dysfunctional adiposity; Stage 2, metabolic risk factors and/or chronic kidney disease; Stage 3, subclinical cardiovascular disease [CVD] or risk equivalents; and Stage 4, clinical CVD. We used survey-weighted multinomial logistic models to examine associations of UPF intake (per 10-percentage-point increment and by quartiles) with CKM stages. We adjusted for age, sex, race and ethnicity, education, family income, smoking status, leisure-time physical activity, and total energy intake. We further adjusted for the Dietary Approaches to Stop Hypertension (DASH) score in sensitivity analyses.
Results
Among 12,372 participants, the median age was 48 years, 51.6% were female, and the prevalence of CKM Stages 0, 1, 2, 3, and 4 was 9.7%, 23.5%, 52.5%, 4.7%, and 9.6%, respectively. Each 10-percentage-point increment in energy intake from UPFs was associated with higher relative risk ratios (RRRs) for CKM Stages 2, 3, and 4 compared with Stage 0: 1.10 (95% CI: 1.03, 1.17), 1.21 (95% CI: 1.11, 1.32), and 1.16 (95% CI: 1.06, 1.27) ( Table 1 ). Compared with adults in the lowest quartile of UPF intake, those in the highest quartile had RRRs of 1.60 (95% CI: 1.15, 2.23), 2.42 (95% CI: 1.50, 3.90), and 2.22 (95% CI: 1.38, 3.55) for CKM Stages 2, 3, and 4, respectively; associations were dose-dependent ( P -trend < 0.01). Associations remained significant for Stages 3 and 4 after adjustment for DASH score. Associations were stronger among females than males ( P -interaction < 0.05) but were consistent across age, race and ethnicity, and family income groups ( Table 2 ).
Conclusions
Higher UPF intake was associated with a higher prevalence of advanced CKM stages among US adults. Associations persisted after adjustment for diet quality and were stronger among females. Reducing UPF consumption may be a modifiable target for clinicians to prioritize in dietary counseling to prevent CKM progression.
Zitieren
APA
Zhang, Y., Steele, E. M., Ndumele, C. E., & Zhang, M. (2026). Abstract FR472: Ultra-Processed Food Consumption and Cardiovascular-Kidney-Metabolic Syndrome Among United States Adults: 2011-2023. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.fr472
Vancouver
Zhang Y, Steele EM, Ndumele CE, Zhang M. Abstract FR472: Ultra-Processed Food Consumption and Cardiovascular-Kidney-Metabolic Syndrome Among United States Adults: 2011-2023. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.fr472
BibTeX
@article{Zhang2026,
author = {Zhang, Yue and Steele, Euridice Martinez and Ndumele, Chiadi E and Zhang, Mingyu},
title = {Abstract FR472: Ultra-Processed Food Consumption and Cardiovascular-Kidney-Metabolic Syndrome Among United States Adults: 2011-2023},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.fr472}
}
EUVIMED